GlassScriptPhysician profile
Steven M Pandelidis
NPI 1902801350
$2,063.07
in general payments reported to CMS, 2019-2025
19 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2021: $122 · 2022: $121 · 2023: $117 · 2024: $165 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,227.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $231.70 | 2019-2025 | Opdivo |
| Novo Nordisk INC | $121.99 | 2021 | |
| Organogenesis INC. | $61.47 | 2024 | |
| Medtronic, INC. | $45.62 | 2022-2025 | Pi |
| Hologic Sales and Service, LLC | $41.26 | 2022 | |
| Solventum Corporation | $41.23 | 2025 | Activ.A.C. |
| Smith+Nephew, INC. | $40.57 | 2023 | Grafix Pl, Stravix Pl, Oasis Micro |
| Kci USA, INC. | $33.88 | 2022-2023 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Lemaitre Vascular, INC. | $32.15 | 2024 | Artegraft Vascular Graft |
| Convatec INC. | $26.85 | 2024 | |
| Kerecis Limited | $23.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Heron Therapeutics, INC. | $21.92 | 2022 | |
| Tela Bio, INC. | $21.82 | 2024 | Ovitex 2s |
| Cardiovascular Systems INC. | $21.58 | 2023 | Diamondback Peripheral |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.29 | 2025 | Keytruda, Lynparza |
| Integra Lifesciences Corporation | $19.48 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Kowa Pharmaceuticals America, INC. | $16.07 | 2023 | Seglentis |
| Davol INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pandelidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.